NPI: 1336556315 · WHARTON, TX
| Year | Claims | Total Paid |
|---|---|---|
| 2021 | 1,034 | $0.00 |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 83970 | 28 | 28 | $0.00 | |
| 85041 | 69 | 63 | $0.00 | |
| 83540 | 27 | 26 | $0.00 | |
| 85045 | 44 | 37 | $0.00 | |
| 84466 | 37 | 37 | $0.00 | |
| 85048 | 69 | 63 | $0.00 | |
| A4657 | Syringe, with or without needle, each | 68 | 67 | $0.00 |
| 82728 | 27 | 26 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 73 | 38 | $0.00 |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 579 | 38 | $0.00 |
| 82306 | 13 | 13 | $0.00 |